查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2041841

兒童體外循環系統市場預測至2034年－按產品、應用、最終用戶和地區分類的全球分析

Pediatric Perfusion Systems Market Forecasts to 2034 - Global Analysis By Product, By Application (Cardiac Surgeries, Organ Transplantation, Extracorporeal Life Support and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球兒童灌注系統市場規模將達到 4.468 億美元，並在預測期內以 8.8% 的複合年成長率成長，到 2034 年將達到 8.773 億美元。

兒童體外循環系統是專為需要在心血管手術中使用心肺體外迴圈的嬰兒童設計的醫療設備。這些系統根據嬰幼兒獨特的生理功能量身定做，包括微型氧合器、幫浦、導管和監測設備。它們在手術過程中維持氧合、體溫調節和血液循環等重要功能，為兒童心血管手術提供安全有效的支持，同時充分考慮了幼齡患者的特殊需求。

根據美國心臟協會 2022 年的情況說明書，預計美國每年約有 40,000 名嬰兒和幼兒出生時患有先天性心臟疾病。

先天性心臟疾病發生率增加

全球嬰兒童先天性心臟疾病發生率的上升是推動兒童體外循環系統市場發展的主要動力。隨著人們對先天性心臟病的認知不斷提高，診斷能力也日益增強，越來越多的病例得以早期發現，從而需要先進的心血管手術。兒童體外循環系統在這些手術中發揮著至關重要的作用，能夠為體型嬌小、生理需求獨特的兒童患者提供量身定做的專業支援。隨著先天性心臟疾病發病率的增加，對矯正性心臟手術的需求也隨之成長，因此，對高效能體外循環系統的需求也日益增加。

設備和手術高成本

兒童體外循環系統及相關手術的高成本是限制市場發展的因素。專為兒童患者設計的特殊設備、嚴格的安全標準和先進的技術都推高了成本。此外，維護和升級這些系統的費用，以及對高技能人員的需求，進一步增加了總支出。高成本限制了某些醫療機構和地區的醫療資源獲取，阻礙了這些系統在兒童心血管手術中的廣泛應用，儘管它們至關重要。

對客製化解決方案的需求日益成長

兒童患者的解剖結構和生理需求各不相同，因此，客製化系統和技術對於滿足這些差異的需求日益受到關注。專注於高度適應性強、以患者為中心的解決方案（例如可調式幫浦、微型氧合器和專用監測設備）的公司可以充分利用這一趨勢。提供滿足特定患者需求的客製化方案，不僅可以改善患者預後，還能建立競爭優勢，並推動兒童灌注系統的創新和市場擴張。

草皮技術的變化

快速的技術變革對市場構成威脅，因為它可能導致現有系統過時。持續的技術進步縮短了設備的使用壽命，可能使現有系統更快被淘汰。這增加了醫療機構的成本，迫使其頻繁升級並投資新技術。此外，培訓員工使用更新的系統並確保其與不斷變化的標準相容，也會帶來後勤方面的挑戰。這種快速的技術發展可能會阻礙對現有解決方案的投資，並影響市場穩定性。

新冠疫情的影響：

新冠疫情對市場造成了衝擊，導致擇期手術（包括兒童心血管手術）中斷，而這些系統對於此類手術至關重要。醫院容量減少、資源重新分配、安全措施導致非緊急手術延期。這暫時降低了對兒童灌注系統的需求，影響了市場成長。然而，由於許多兒童心血管手術屬於緊急手術，儘管面臨這些挑戰，市場需求仍維持在一定水平。

在預測期內，兒童氧合設備細分市場預計將成為最大的細分市場。

預計兒童氧合設備細分市場將引領市場成長，因為它在兒童心血管手術中發揮至關重要的作用，能夠提供必要的氧合支持。這些手術需要精準且個人化的氧合，以適應兒童血液容積少和獨特的生理功能，因此專用氧合設備不可或缺。此外，先天性心臟疾病率的上升和兒童心臟治療需求的增加，也推動了對高效且適應性強的氧合設備的需求，使該細分市場成為兒童灌注系統的基石，並有望保持其市場主導地位。

在預測期內，製藥和生技公司板塊預計將呈現最高的複合年成長率。

預計製藥和生技公司板塊將達到最高成長率，主要得益於其加大對兒童灌注系統的研發投入。這些公司正大力投資創新技術、藥物研發以及兒童心血管手術專用設備。隨著人們越來越關注為兒童患者提供個人化解決方案，製藥和生物技術公司正主導先進灌注系統的研發，預計這將推動該板塊在預測期內實現高速成長。

市佔率最大的地區：

由於北美擁有先進的醫療基礎設施、大量的研發投入以及先天性心臟疾病的高發病率，預計北美將佔據最大的市場佔有率。此外，該地區已建立起完善的兒童心臟中心，並在研究機構和製藥公司之間建立了成熟的合作網路。憑藉有利的醫保報銷政策和主要市場參與者的存在，北美在先進兒童灌注系統的引進和應用方面具有競爭優勢，從而確保了其可觀的市場佔有率。

複合年成長率最高的地區：

由於醫療保健支出不斷成長、人們對兒童心臟病護理的認知日益提高以及兒童人口持續成長，亞太地區預計將迎來顯著成長。新興經濟體的醫療基礎設施不斷完善，技術不斷進步，推動了對先進灌注系統的需求。此外，與全球企業的合作、政府主導的各項措施以及兒童心臟外科中心的擴建，都促進了該地區在先進兒童灌注系統的應用和整合方面的巨大成長潛力。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球兒童灌流系統市場：依產品分類

  • 監控系統
  • 兒童動脈濾器
  • 兒童血液泵
  • 兒童套管和導管
  • 兒童氧氣輸送裝置
  • 其他產品

第6章 全球兒童灌流系統市場：依應用分類

  • 心血管手術
  • 器官移植
  • 體外生命維持裝置（ECLS/ECMO）
  • 其他用途

第7章 全球兒童灌流系統市場：依最終用戶分類

  • 醫院
  • 專科診所
  • 門診手術中心
  • 製藥和生物技術公司
  • 其他最終用戶

第8章 全球兒童灌流系統市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • Baxter International Inc.
  • Braile Biomedica
  • Edwards Lifesciences Corporation
  • Getinge Group
  • Hemovent GmbH
  • LeMaitre Vascular, Inc.
  • LivaNova
  • Medtronic
  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Perfusion.com, Inc.
  • Sorin Group
  • Spectrum Medical
  • Stryker Corporation
  • Terumo Cardiovascular
  • Xenios AG
Product Code: SMRC24907

According to Stratistics MRC, the Global Pediatric Perfusion Systems Market is accounted for $446.8 million in 2026 and is expected to reach $877.3 million by 2034 growing at a CAGR of 8.8% during the forecast period. Pediatric perfusion systems are specialised medical setups crafted specifically for infants and children requiring cardiopulmonary bypass during cardiac surgeries. Tailored to their unique physiologies, these systems include smaller oxygenators, pumps, tubing and monitoring devices. They maintain vital functions like oxygenation, temperature control and blood circulation during procedures, ensuring safe and effective support for pediatric cardiac surgery while considering the unique needs of younger patients.

According to American Heart Association, Inc.'s fact sheet 2022, congenital heart defects are expected to affect around 40,000 infants in the U.S. each year.

Market Dynamics:

Driver:

Rising incidence of congenital heart defects

The increasing prevalence of congenital heart defects among infants and children globally serves as a significant driver in the pediatric Perfusion systems market. With rising awareness and improved diagnostic capabilities, more cases are being identified early, necessitating advanced cardiac surgeries. Pediatric perfusion systems play a crucial role in these surgeries, providing specialised support tailored to the smaller anatomies and unique physiological requirements of pediatric patients. As the demand for corrective cardiac procedures rises due to the growing incidence of congenital heart defects, the need for effective perfusion systems amplifies accordingly.

Restraint:

High cost of equipment and procedures

The high cost associated with pediatric perfusion systems and related procedures poses a significant restraint on the market. The specialised nature of equipment tailored for pediatric patients, coupled with stringent safety standards and advanced technologies, contributes to elevated costs. Additionally, the expenses incurred in maintaining and upgrading these systems, along with the need for highly skilled personnel, further escalate the overall expenditure. This high cost limits accessibility for certain healthcare facilities or regions, hindering widespread adoption despite the critical need for these systems in pediatric cardiac surgeries.

Opportunity:

Growing demand for customized solutions

Pediatric patients exhibit diverse anatomies and physiological needs, and there's a growing emphasis on tailored systems and technologies to address these variations. Companies focusing on adaptable, patient-specific solutions, such as adjustable pumps, smaller oxygenators, and specialised monitoring devices, can capitalise on this trend. Offering customised options that cater to specific patient requirements not only enhances patient outcomes but also establishes a competitive edge, fostering innovation and market expansion in pediatric perfusion systems.

Threat:

Rapid technological changes

Rapid technological changes pose a threat to the market due to the risk of rendering existing systems obsolete. Continuous advancements may lead to shorter lifecycles for equipment, potentially making current systems outdated faster. This necessitates frequent upgrades or investments in newer technologies, increasing costs for healthcare facilities. Additionally, the need for training staff on updated systems and ensuring compatibility with evolving standards can create logistical challenges. This swift pace of technological evolution might deter investments in current solutions, impacting market stability.

Covid-19 Impact:

The COVID-19 pandemic has influenced the market by causing disruptions in elective surgeries, including pediatric cardiac procedures, where these systems are crucial. Reduced hospital capacities, redirected resources, and safety measures resulted in deferred non-emergency surgeries. This decreased demand for pediatric perfusion systems temporarily, affecting market growth. However, the urgent nature of many pediatric cardiac surgeries has sustained some demand despite these challenges.

The pediatric oxygenators segment is expected to be the largest during the forecast period

The pediatric oxygenators segment is anticipated to dominate due to its pivotal role in providing essential oxygenation support during pediatric cardiac surgeries. As these procedures require precise and tailored oxygenation for smaller blood volumes and unique pediatric physiology, specialised oxygenators are crucial. Additionally, the rising incidence of congenital heart defects and the demand for pediatric cardiac interventions drive the need for efficient and adaptable oxygenators, positioning this segment as a cornerstone in pediatric perfusion systems and thus driving its expected market dominance.

The pharmaceutical and biotech companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical and biotech companies segment anticipates the highest growth rate owing to increased research and development focused on pediatric perfusion systems. These companies invest extensively in innovative technologies, drug development and specialised equipment catering to pediatric cardiac surgeries. With a growing emphasis on tailored solutions for pediatric patients, pharmaceutical and biotech firms are leading in developing advanced perfusion systems, thus driving the projected high growth rate in this segment during the forecast period.

Region with largest share:

North America is positioned to hold the largest market share due to advanced healthcare infrastructure, substantial R&D investments, and a high prevalence of congenital heart defects. Additionally, the region boasts well-established pediatric cardiac centers and collaborations between research institutes and pharmaceutical companies. Favorable reimbursement policies and the presence of key market players further contribute to North America's dominance in adopting and implementing sophisticated pediatric perfusion systems, securing a significant market share.

Region with highest CAGR:

The Asia-Pacific region is set to experience significant growth owing to the rising healthcare expenditure, increasing awareness about pediatric cardiac care and a growing pediatric population. Emerging economies are witnessing improvements in healthcare infrastructure and technology adoption, fostering the demand for advanced perfusion systems. Moreover, collaborations with global players, government initiatives and expanding pediatric cardiac surgery centres contribute to the region's substantial growth potential in adopting and integrating sophisticated pediatric perfusion systems.

Key players in the market

Some of the key players in Pediatric Perfusion Systems Market include Baxter International Inc., Braile Biomedica, Edwards Lifesciences Corporation, Getinge Group, Hemovent GmbH, LeMaitre Vascular, Inc., LivaNova, Medtronic, MicroPort Scientific Corporation, Nipro Medical Corporation, Perfusion.com, Inc., Sorin Group, Spectrum Medical, Stryker Corporation, Terumo Cardiovascular and Xenios AG.

Key Developments:

In December 2023, Vascular Perfusion Solutions (VPS), Inc., is a San Antonio based medical device startup company focused on developing novel prolonged organ preservation technologies prior to transplantation, has received a $25,000 grant from the Southwest-Midwest National Pediatric Device Innovation Consortium (SWPDC).

In March 2023, LivaNova PLC, a market-leading medical technology and innovation company, announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz(TM) Heart-Lung Machine (HLM). With FDA clearance, LivaNova initiates the commercial launch of Essenz in the U.S. The Company also recently received approval for the Essenz HLM from Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

Products Covered:

  • Monitoring Systems
  • Pediatric Arterial Filters
  • Pediatric Blood Pumps
  • Pediatric Cannulas and Catheters
  • Pediatric Oxygenators
  • Other Products

Applications Covered:

  • Cardiac Surgeries
  • Organ Transplantation
  • Extracorporeal Life Support (ECLS/ECMO)
  • Other Applications

End Users Covered:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Pharmaceutical and Biotech Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pediatric Perfusion Systems Market, By Product

  • 5.1 Introduction
  • 5.2 Monitoring Systems
  • 5.3 Pediatric Arterial Filters
  • 5.4 Pediatric Blood Pumps
  • 5.5 Pediatric Cannulas and Catheters
  • 5.6 Pediatric Oxygenators
  • 5.7 Other Products

6 Global Pediatric Perfusion Systems Market, By Application

  • 6.1 Introduction
  • 6.2 Cardiac Surgeries
  • 6.3 Organ Transplantation
  • 6.4 Extracorporeal Life Support (ECLS/ECMO)
  • 6.5 Other Applications

7 Global Pediatric Perfusion Systems Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Specialty Clinics
  • 7.4 Ambulatory Surgical Centers
  • 7.5 Pharmaceutical and Biotech Companies
  • 7.6 Other End Users

8 Global Pediatric Perfusion Systems Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Baxter International Inc.
  • 10.2 Braile Biomedica
  • 10.3 Edwards Lifesciences Corporation
  • 10.4 Getinge Group
  • 10.5 Hemovent GmbH
  • 10.6 LeMaitre Vascular, Inc.
  • 10.7 LivaNova
  • 10.8 Medtronic
  • 10.9 MicroPort Scientific Corporation
  • 10.10 Nipro Medical Corporation
  • 10.11 Perfusion.com, Inc.
  • 10.12 Sorin Group
  • 10.13 Spectrum Medical
  • 10.14 Stryker Corporation
  • 10.15 Terumo Cardiovascular
  • 10.16 Xenios AG

List of Tables

  • Table 1 Global Pediatric Perfusion Systems Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pediatric Perfusion Systems Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2023-2034) ($MN)
  • Table 4 Global Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2023-2034) ($MN)
  • Table 5 Global Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2023-2034) ($MN)
  • Table 6 Global Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2023-2034) ($MN)
  • Table 7 Global Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2023-2034) ($MN)
  • Table 8 Global Pediatric Perfusion Systems Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 9 Global Pediatric Perfusion Systems Market Outlook, By Application (2023-2034) ($MN)
  • Table 10 Global Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2023-2034) ($MN)
  • Table 11 Global Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 12 Global Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2023-2034) ($MN)
  • Table 13 Global Pediatric Perfusion Systems Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 14 Global Pediatric Perfusion Systems Market Outlook, By End User (2023-2034) ($MN)
  • Table 15 Global Pediatric Perfusion Systems Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 16 Global Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 17 Global Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 18 Global Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2023-2034) ($MN)
  • Table 19 Global Pediatric Perfusion Systems Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 20 North America Pediatric Perfusion Systems Market Outlook, By Country (2023-2034) ($MN)
  • Table 21 North America Pediatric Perfusion Systems Market Outlook, By Product (2023-2034) ($MN)
  • Table 22 North America Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2023-2034) ($MN)
  • Table 23 North America Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2023-2034) ($MN)
  • Table 24 North America Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2023-2034) ($MN)
  • Table 25 North America Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2023-2034) ($MN)
  • Table 26 North America Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2023-2034) ($MN)
  • Table 27 North America Pediatric Perfusion Systems Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 28 North America Pediatric Perfusion Systems Market Outlook, By Application (2023-2034) ($MN)
  • Table 29 North America Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2023-2034) ($MN)
  • Table 30 North America Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 31 North America Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2023-2034) ($MN)
  • Table 32 North America Pediatric Perfusion Systems Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 33 North America Pediatric Perfusion Systems Market Outlook, By End User (2023-2034) ($MN)
  • Table 34 North America Pediatric Perfusion Systems Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 35 North America Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 36 North America Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 37 North America Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2023-2034) ($MN)
  • Table 38 North America Pediatric Perfusion Systems Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 39 Europe Pediatric Perfusion Systems Market Outlook, By Country (2023-2034) ($MN)
  • Table 40 Europe Pediatric Perfusion Systems Market Outlook, By Product (2023-2034) ($MN)
  • Table 41 Europe Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2023-2034) ($MN)
  • Table 42 Europe Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2023-2034) ($MN)
  • Table 43 Europe Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2023-2034) ($MN)
  • Table 44 Europe Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2023-2034) ($MN)
  • Table 45 Europe Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2023-2034) ($MN)
  • Table 46 Europe Pediatric Perfusion Systems Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 47 Europe Pediatric Perfusion Systems Market Outlook, By Application (2023-2034) ($MN)
  • Table 48 Europe Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2023-2034) ($MN)
  • Table 49 Europe Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 50 Europe Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2023-2034) ($MN)
  • Table 51 Europe Pediatric Perfusion Systems Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 52 Europe Pediatric Perfusion Systems Market Outlook, By End User (2023-2034) ($MN)
  • Table 53 Europe Pediatric Perfusion Systems Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 54 Europe Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 55 Europe Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 56 Europe Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2023-2034) ($MN)
  • Table 57 Europe Pediatric Perfusion Systems Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 58 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Country (2023-2034) ($MN)
  • Table 59 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Product (2023-2034) ($MN)
  • Table 60 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2023-2034) ($MN)
  • Table 61 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2023-2034) ($MN)
  • Table 62 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2023-2034) ($MN)
  • Table 63 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2023-2034) ($MN)
  • Table 64 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2023-2034) ($MN)
  • Table 65 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 66 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Application (2023-2034) ($MN)
  • Table 67 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2023-2034) ($MN)
  • Table 68 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 69 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2023-2034) ($MN)
  • Table 70 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 71 Asia Pacific Pediatric Perfusion Systems Market Outlook, By End User (2023-2034) ($MN)
  • Table 72 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 73 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 74 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 75 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2023-2034) ($MN)
  • Table 76 Asia Pacific Pediatric Perfusion Systems Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 77 South America Pediatric Perfusion Systems Market Outlook, By Country (2023-2034) ($MN)
  • Table 78 South America Pediatric Perfusion Systems Market Outlook, By Product (2023-2034) ($MN)
  • Table 79 South America Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2023-2034) ($MN)
  • Table 80 South America Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2023-2034) ($MN)
  • Table 81 South America Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2023-2034) ($MN)
  • Table 82 South America Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2023-2034) ($MN)
  • Table 83 South America Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2023-2034) ($MN)
  • Table 84 South America Pediatric Perfusion Systems Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 85 South America Pediatric Perfusion Systems Market Outlook, By Application (2023-2034) ($MN)
  • Table 86 South America Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2023-2034) ($MN)
  • Table 87 South America Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 88 South America Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2023-2034) ($MN)
  • Table 89 South America Pediatric Perfusion Systems Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 90 South America Pediatric Perfusion Systems Market Outlook, By End User (2023-2034) ($MN)
  • Table 91 South America Pediatric Perfusion Systems Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 92 South America Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 93 South America Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 94 South America Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2023-2034) ($MN)
  • Table 95 South America Pediatric Perfusion Systems Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 96 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Country (2023-2034) ($MN)
  • Table 97 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Product (2023-2034) ($MN)
  • Table 98 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Monitoring Systems (2023-2034) ($MN)
  • Table 99 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Pediatric Arterial Filters (2023-2034) ($MN)
  • Table 100 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Pediatric Blood Pumps (2023-2034) ($MN)
  • Table 101 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Pediatric Cannulas and Catheters (2023-2034) ($MN)
  • Table 102 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Pediatric Oxygenators (2023-2034) ($MN)
  • Table 103 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 104 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Application (2023-2034) ($MN)
  • Table 105 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Cardiac Surgeries (2023-2034) ($MN)
  • Table 106 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Organ Transplantation (2023-2034) ($MN)
  • Table 107 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Extracorporeal Life Support (ECLS/ECMO) (2023-2034) ($MN)
  • Table 108 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 109 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By End User (2023-2034) ($MN)
  • Table 110 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 111 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 112 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 113 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Pharmaceutical and Biotech Companies (2023-2034) ($MN)
  • Table 114 Middle East & Africa Pediatric Perfusion Systems Market Outlook, By Other End Users (2023-2034) ($MN)